Innovative Eyewear announced preliminary Q3 2026 net sales of approximately $1.04 million, a 55% increase year-over-year and the highest quarterly sales in company history. The company also reported a 66% increase in net sales for the first nine months of 2026 compared to 2025, surpassing the full-year sales of 2025. Growth was driven by a 25% rise in direct-to-consumer sales and initial shipments from new wholesale partnerships in the US, Canada, and Australia/New Zealand. The company plans to launch its new Lucyd Aero™ smart eyewear in Q4 2026, expecting stronger sales from expanded wholesale channels into 2027.
Innovative Eyewear's record preliminary Q3 2026 net sales provide context for the consumer cyclical sector, where as of Oct 06, 2026 18:14 WIB, 73 of 112 priced US stocks rose and 29 fell on Pluang. Notable movers include Harley-Davidson Inc (HOG) at USD 26.50 with a 1-day change of +1.18% and 100% buy order activity, Tesla, Inc. (TSLA) at USD 382.90 with a +1.10% change and 65% sell order activity, and Quantumscape Corp (QS) at USD 4.67 with a +1.08% change and 85% buy order activity. The most notable figure is Harley-Davidson's 100% buy order activity on Pluang.
Morgan Stanley analyst Bob Huang lowered American International Group's (AIG) price target to $80 from $81, with the stock trading around $76, indicating potential upside. AIG is set to report its Q3 2026 earnings on November 3, with investors focuse...
Vertiv Holdings, a maker of power and cooling equipment for data centers, faces mixed analyst opinions with GLJ Research rating it a "Sell" and BMO Capital giving an "Outperform" rating. Despite a recent stock pullback, the company reported a 241% in...
Apogee Enterprises reported strong fiscal Q2 results with adjusted earnings of $1.17 per share, nearly double the estimated $0.59, and revenue of $391.14 million, surpassing expectations of $362.6 million. This marks a continued trend of beating esti...
McKesson received a bullish price target of $977 from Morgan Stanley, suggesting a 6.7% upside from its current price of $915.45. The company agreed to acquire Option Care Health for $32.05 per share, valuing the deal at approximately $5.8 billion in...
Ameriprise Financial has authorized an additional $5.5 billion for share repurchases through September 2028, supported by $2.1 billion in excess capital and $2.8 billion in liquidity. The company returned $1.9 billion to shareholders in H1 2026, incl...
